x
Filter:
Filters applied
- ACMG Statements and Guidelines
- Matalon, Dena RRemove Matalon, Dena R filter
- Informed consentRemove Informed consent filter
Publication Date
Please choose a date range between 2021 and 2021.
ACMG Statements and Guidelines
These online statements and guidelines are definitive and may be cited using the digital object identifier (DOI). These recommendations are designed primarily as an educational resource for medical geneticists and other healthcare providers to help them provide quality medical genetics services; they should not be considered inclusive of all proper procedures and tests or exclusive of other procedures and tests that are reasonably directed to obtaining the same results. Please refer to the leading disclaimer in each document for more information.
1 Results
- ACMG StatementOpen Archive
Points to consider to avoid unfair discrimination and the misuse of genetic information: A statement of the American College of Medical Genetics and Genomics (ACMG)
Genetics in MedicineVol. 24Issue 3p512–520Published online: December 16, 2021- Laurie H. Seaver
- George Khushf
- Nancy M.P. King
- Dena R. Matalon
- Kunal Sanghavi
- Matteo Vatta
- and others
Cited in Scopus: 3In this era of precision medicine, the incorporation of genetic and genomic information, herein referred to as genetic information, into health care has gained unprecedented attention. As a result of the rapid decline in the cost of DNA sequencing, these data are now routinely used for diagnostic purposes and preventive health screening. In addition to the application of genetic information to support diagnosis and management, consumers may directly access various genetic testing–based products for medical and nonmedical uses, and some employers now offer wellness genetic testing to their employees as a benefit.
